increase in diacylglycerol concentration stimulated by interferon can be correlated to the interferon-induced inhibition of Daudi cell division in a dose-responsive manner. Phorbol 12-myristate 13-acetate also inhibits Daudi cell division in a dose-responsive manner. It is likely that the sharp and transient increase in diacylglycerol concentration represents one of the early biochemical changes in Daudi cells exposed to interferon.
Although much is known of the biological effects as well as the biochemical reactions associated with interferon in vitro, little is known of the role of interferon in vivo (1) (2) (3) (4) . Equally little is known of the mechanism by which interferon produces its effect at the level of its receptor. Presumably, interferon interacts with its receptor, initiating signals from the cell surface into the cell and its nucleus. The transmission of these cellular signals into the nucleus initiates the transcription of specific genes (5) (6) (7) (8) (9) (10) . The products of these genes convert the cell into an altered physiological state. Alternatively, the interaction between interferon and its receptor itself may be sufficient to produce this state. Recent advances in interferon receptor studies show that there are two types of human interferon receptors. One, which binds human p-interferon, is a product of a chromosome 21 gene (11, 12) . Another, which binds human y-interferon, is a product of a chromosome 6 gene (13) .
In this paper, we investigate the early events that occur after Daudi cells are incubated with human p-interferon. We report that a rapid and transient increase in diacylglycerol concentration occurs in Daudi cells within seconds of their exposure to interferon.
MATERIALS AND METHODS
Interferons, Anti-Interferon Antibodies, and Cells. Human p3-interferon was prepared in 2-mg batches from primary diploid human fibroblasts by the method of Tan and coworkers (14, 15) and purified to homogeneity by Blue Sepharose column chromatography followed by chromatography on a reversed-phase HPLC column (16) . The purity of the interferon was verified by NaDodSO4/PAGE. The purified interferon was used as an immunogen to generate antibodies in New Zealand White rabbits as described (17 Habenicht et al. (21) . Daudi cells were grown in RPMI 1640 medium containing 10% (vol/vol) fetal bovine serum (regular medium) and [2- 3H]glycerol (Amersham; 6 ,uCi/ml; 1 Ci = 37 GBq) for about 42 hr. The cells were washed to remove unincorporated labeled glycerol and resuspended in regular medium at 1.25 x 107 cells per ml. Aliquots (0.4 ml, 5 x 106 cells) in triplicate were dispensed into Eppendorf tubes and subjected to treatment with various concentrations of interferon for the times indicated in the figures. Generally, the range of radioactivity incorporated into the cells was 500,000-800,000 cpm for each set of 5 x 106 cells. The cells were extracted for lipid by the method of Bligh and Dyer (22) . The extracted lipid with added unlabeled diacylglycerol was quantitatively analyzed by silica gel G thin-layer plastic plate (Eastman Kodak) chromatography. The chromatography was performed in Abbreviations: PMA, phorbol 12-myristate 13-acetate; IU, international unit(s).
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RESULTS
Purity of Human P-Interferon. The elution of human p-interferon from a reversed-phase HPLC column is described in Fig. 1 , and the purity of the interferon in fraction B is indicated by NaDodSO4/PAGE analysis (see Fig. 1 Inset).
Polyclonal Anti-Interferon Antibody Inhibits the Binding of Interferon to its Receptor. Daudi cells were incubated with saturating levels of 1251-labeled human p-interferon in the absence or presence of a 3-and 10-fold excess of antiinterferon antibody, as well as in the absence or presence of a 100-fold excess ofunlabeled human P-interferon. Unlabeled human P-interferon competed with 125I-labeled p-interferon for binding to Daudi cells. Rabbit anti-interferon antibody reduced the binding of '25I-labeled interferon to Daudi cells (Table 1) .
Increased Diacylglycerol Concentration in Daudi Cells Treated with Interferon. When Daudi cells were incubated with human /3-interferon (20,000 IU/ml) at 370C, the concentration of diacylglycerol was found to increase within seconds. By 30 sec, the concentration of diacylglycerol was about 4-fold higher than that in cells not treated with interferon. Thereafter, diacylglycerol concentration declined rapidly (within minutes) and was restored to about basal level 10 min after interferon treatment (Fig. 2) . This observation is consistently reproducible in Daudi cells incubated with human p-interferon. A rise in diacylglycerol was not observed if the human p-interferon was rendered biologically inactive by preincubation with rabbit anti-p-interferon serum (Fig. 2) (Fig. 3) . Cell Biology: Yap et al. (Fig. 3) Table 2 ). It is likely that this is an interferon-associated effect (Fig. 1) . One of the first reactions between interferon and cells is the binding of interferon to its receptor, resulting in formation of an interferon-receptor complex (20) . Preincubation of human p-interferon with its antibody prevents interferon from binding to its receptor sites and thus neutralizes the inhibition of Daudi cell division by interferon (Table  1 and Fig. 3) . Similarly, preincubation of interferon with its antibody also abolishes the rapid and transient rise in diacylglycerol concentration in Daudi cells (Fig. 2) . In contrast, human -y-interferon has no effect on cell division (data not shown) and does not stimulate an increase in diacylglycerol concentration. in Daudi cells ( to the size of the increase in cellular diacylglycerol (Fig. 3) (Table 3) . PMA has been reported to mimic the effect of diacylglycerol by activating protein kinase C directly (28 In any event, the data indicate that the degradation of phospholipids constitutes one of the early events of interferon action. The identification of the principal enzymes involved in this process is key to the elucidation of the biochemical pathway for the transduction of the interferon signal from the cell surface into the cell.
